Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions

Area of Science:

• Immunology
• Cell Biology
• Autoimmunity

Background:

• B cells are key regulators of immune responses, primarily through antibody production.
• Certain B cell subsets, known as regulatory B cells (B10 cells), can suppress immune responses by secreting interleukin-10 (IL-10).
• B10 cells are potent regulators of T-cell-dependent autoimmune diseases in mice, but their in vivo regulation is not fully understood.

Purpose of the Study:

• To investigate the mechanisms controlling B10 cell IL-10 production and immune regulation in vivo.
• To explore the potential of ex vivo expanded B10 cells as a therapeutic strategy for autoimmune diseases.

Main Methods:

• Utilized a mouse model of multiple sclerosis to study B10 cell function.
• Investigated the roles of IL-21 and CD40-dependent T cell interactions in B10 cell maturation.
• Performed ex vivo expansion of B10 cells using CD40 and IL-21 receptor signals.
• Transferred expanded B10 cells into mice with established autoimmune disease.

Main Results:

• B10 cell maturation into IL-10 secreting effector cells requires IL-21 and CD40-dependent T cell cognate interactions.
• Ex vivo expansion of B10 cells using CD40 and IL-21 receptor signals resulted in a four-million-fold increase.
• Adoptive transfer of expanded B10 cells significantly inhibited autoimmune disease symptoms in mice.

Conclusions:

• IL-21 and T cell interactions are critical for the development and function of IL-10-producing B10 cells in vivo.
• Ex vivo expansion and reinfusion of autologous B10 cells represent a promising therapeutic approach for severe autoimmune diseases.
• This strategy may offer a novel treatment for autoimmune conditions resistant to current therapies.